Insufficient scRNA-seq data for expression of SPHK2 at single-cell level.
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 25% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 1585.45 | 966 / 966 | 100% | 13.52 | 527 / 527 |
brain | 100% | 2392.65 | 2640 / 2642 | 100% | 18.03 | 705 / 705 |
esophagus | 100% | 1131.54 | 1441 / 1445 | 100% | 8.86 | 183 / 183 |
ovary | 100% | 1636.00 | 180 / 180 | 100% | 12.24 | 428 / 430 |
bladder | 100% | 1183.86 | 21 / 21 | 99% | 11.30 | 500 / 504 |
prostate | 100% | 1560.64 | 245 / 245 | 99% | 12.16 | 498 / 502 |
thymus | 100% | 1974.46 | 653 / 653 | 99% | 10.49 | 600 / 605 |
stomach | 100% | 1286.57 | 359 / 359 | 99% | 13.41 | 283 / 286 |
uterus | 100% | 1415.15 | 170 / 170 | 98% | 8.20 | 451 / 459 |
breast | 100% | 1132.92 | 459 / 459 | 97% | 7.50 | 1088 / 1118 |
kidney | 100% | 2052.62 | 89 / 89 | 97% | 6.69 | 874 / 901 |
skin | 97% | 713.85 | 1760 / 1809 | 98% | 11.02 | 462 / 472 |
lung | 97% | 1021.73 | 561 / 578 | 98% | 7.81 | 1131 / 1155 |
adrenal gland | 100% | 1154.74 | 257 / 258 | 95% | 8.49 | 219 / 230 |
liver | 100% | 1707.13 | 225 / 226 | 95% | 8.26 | 385 / 406 |
pancreas | 95% | 612.58 | 313 / 328 | 97% | 8.75 | 173 / 178 |
eye | 0% | 0 | 0 / 0 | 100% | 10.20 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 10.74 | 29 / 29 |
spleen | 100% | 1302.20 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 7.19 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.18 | 1 / 1 |
adipose | 100% | 1032.54 | 1201 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1060.13 | 1330 / 1335 | 0% | 0 | 0 / 0 |
muscle | 88% | 499.90 | 709 / 803 | 0% | 0 | 0 / 0 |
heart | 88% | 501.08 | 756 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 84% | 730.87 | 777 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043306 | Biological process | positive regulation of mast cell degranulation |
GO_0030148 | Biological process | sphingolipid biosynthetic process |
GO_1904628 | Biological process | cellular response to phorbol 13-acetate 12-myristate |
GO_0006669 | Biological process | sphinganine-1-phosphate biosynthetic process |
GO_0006670 | Biological process | sphingosine metabolic process |
GO_0008283 | Biological process | cell population proliferation |
GO_1904959 | Biological process | regulation of cytochrome-c oxidase activity |
GO_0002720 | Biological process | positive regulation of cytokine production involved in immune response |
GO_0032736 | Biological process | positive regulation of interleukin-13 production |
GO_0090280 | Biological process | positive regulation of calcium ion import |
GO_1903426 | Biological process | regulation of reactive oxygen species biosynthetic process |
GO_2001169 | Biological process | regulation of ATP biosynthetic process |
GO_2000304 | Biological process | positive regulation of ceramide biosynthetic process |
GO_0003376 | Biological process | sphingosine-1-phosphate receptor signaling pathway |
GO_0046512 | Biological process | sphingosine biosynthetic process |
GO_0001568 | Biological process | blood vessel development |
GO_0090037 | Biological process | positive regulation of protein kinase C signaling |
GO_0007420 | Biological process | brain development |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0016310 | Biological process | phosphorylation |
GO_0043122 | Biological process | regulation of canonical NF-kappaB signal transduction |
GO_0033008 | Biological process | positive regulation of mast cell activation involved in immune response |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0045815 | Biological process | transcription initiation-coupled chromatin remodeling |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0030308 | Biological process | negative regulation of cell growth |
GO_0000786 | Cellular component | nucleosome |
GO_0016020 | Cellular component | membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005634 | Cellular component | nucleus |
GO_0042393 | Molecular function | histone binding |
GO_0017050 | Molecular function | D-erythro-sphingosine kinase activity |
GO_0031267 | Molecular function | small GTPase binding |
GO_0001727 | Molecular function | lipid kinase activity |
GO_0038036 | Molecular function | sphingosine-1-phosphate receptor activity |
GO_0008481 | Molecular function | sphinganine kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SPHK2 |
Protein name | Sphingosine kinase 2 (SK 2) (SPK 2) (EC 2.7.1.91) Sphingosine kinase 2 |
Synonyms | SK2 hCG_15274 |
Description | FUNCTION: Catalyzes the phosphorylation of sphingosine to form sphingosine-1-phosphate (SPP), a lipid mediator with both intra- and extracellular functions. Also acts on D-erythro-dihydrosphingosine, D-erythro-sphingosine and L-threo-dihydrosphingosine. Binds phosphoinositides . In contrast to prosurvival SPHK1, has a positive effect on intracellular ceramide levels, inhibits cells growth and enhances apoptosis . In mitochondria, is important for cytochrome-c oxidase assembly and mitochondrial respiration. The SPP produced in mitochondria binds PHB2 and modulates the regulation via PHB2 of complex IV assembly and respiration . In nucleus, plays a role in epigenetic regulation of gene expression. Interacts with HDAC1 and HDAC2 and, through SPP production, inhibits their enzymatic activity, preventing the removal of acetyl groups from lysine residues with histones. Up-regulates acetylation of histone H3-K9, histone H4-K5 and histone H2B-K12 . In nucleus, may have an inhibitory effect on DNA synthesis and cell cycle . In mast cells, is the main regulator of SPP production which mediates calcium influx, NF-kappa-B activation, cytokine production, such as TNF and IL6, and degranulation of mast cells (By similarity). In dopaminergic neurons, is involved in promoting mitochondrial functions regulating ATP and ROS levels (By similarity). Also involved in the regulation of glucose and lipid metabolism (By similarity). . |
Accessions | ENST00000599029.2 ENST00000245222.9 [Q9NRA0-1] ENST00000340932.7 E7ET12 ENST00000598088.5 [Q9NRA0-1] ENST00000600537.5 [Q9NRA0-4] ENST00000593308.1 Q9NRA0 E9PCV4 ENST00000599748.5 [Q9NRA0-2] ENST00000597434.5 A0A075B7A1 ENST00000601712.5 ENST00000426514.2 M0QZP3 M0R344 M0R0E9 M0QXX5 ENST00000601704.1 |